# A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

> **NCT04067583** · — · COMPLETED · sponsor: **Bayer** · enrollment: 454 (actual)

## Conditions studied

- Ophthalmology, Macular Degeneration

## Interventions

- **OTHER:** Physician questionnaire

## Key facts

- **NCT ID:** NCT04067583
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-08
- **Primary completion:** 2020-04-15
- **Final completion:** 2020-04-23
- **Target enrollment:** 454 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04067583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04067583, "A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04067583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*